Analysis
Scan.com closed $220 million in combined equity and debt financing to expand its US diagnostic-imaging network, the company announced.
The structure, in two pieces:
- Series C equity -- led by Noteus Partners, with Aviva, Concord Health Partners, YZR Capital and Oxford Capital also participating.
- Debt facility -- from VerisFi Capital and Atempo Growth, making up the larger share of the combined raise and earmarked for acquisitions and working capital.
“The structure, in two pieces: - Series C equity -- led by Noteus Partners, with Aviva, Concord Health Partners, YZR Capital and Oxford Capital also participating.”
Scan.com operates a booking and referral marketplace that connects patients and physicians to independent MRI, CT and X-ray imaging centers, rather than owning the imaging equipment itself. The pitch is that most US markets already have enough scanner capacity; what's missing is a system that can find an open slot, verify insurance coverage and route a patient to the right center within days instead of the multi-week waits common at hospital-affiliated radiology departments.
Why the Debt Component Matters as Much as the Equity
The $130 million debt facility is larger than the equity round itself, which is the more telling number in this deal. Diagnostic-imaging marketplaces scale by adding imaging-center partners and, increasingly, by acquiring smaller booking networks and regional aggregators outright -- both of which are more efficiently funded with debt than with dilutive equity once a company has predictable, contracted revenue from imaging-center referral fees. The structure signals Scan.com's lenders believe the referral-fee revenue is stable enough to underwrite against, which is a different and arguably stronger validation than a growth-equity mark alone.
The Competitive Field
Health-tech booking marketplaces have had a mixed track record: many consumer-facing scheduling startups from the 2015-2020 cohort struggled because health systems controlled the actual appointment slots and had little incentive to expose them to a third-party marketplace. Scan.com's bet is that independent imaging centers -- which compete on utilization in a way hospital radiology departments don't -- have the opposite incentive, making them a more willing supply side. The company sits in the same broad diagnostics-access category as RadNet's outpatient network and various physician-referral platforms, though most of those are either vertically integrated imaging-center operators or narrower single-specialty tools rather than open marketplaces.
The Bear Case
The risk is concentration on the supply side: if imaging-center margins compress as more of them list on marketplaces like Scan.com, the referral-fee model that underwrites the debt facility gets squeezed from both directions -- centers demanding lower fees to stay profitable, and Scan.com needing higher volume to service $130 million in new debt. Digital health funding overall reached $7.4 billion in the first half of 2026, and the category has increasingly rewarded companies with proven unit economics over ones still proving out a marketplace model, so the debt investors' underwriting will be tested quickly.
For healthcare-focused investors, the number to track is imaging-center partner retention and referral-fee stability over the next two quarters -- that ratio determines whether $220 million was a growth bet or a bridge to acquisition.
